Cynarin attenuates LPS-induced endothelial inflammation via upregulation of the negative regulator MKP-3
- PMID: 35784390
- PMCID: PMC9246029
- DOI: 10.1080/19768354.2022.2077438
Cynarin attenuates LPS-induced endothelial inflammation via upregulation of the negative regulator MKP-3
Abstract
Clinical observations have revealed that non-resolving low-grade inflammation is linked to the pathogenesis of chronic inflammatory diseases, for example arthritis, atherosclerosis, Alzheimer's disease, diabetes, and chronic kidney disease. Interestingly, low levels of circulating lipopolysaccharides (LPS) derived from the outer membrane of gram-negative bacteria appear to be one of the primary causes of persistent low-grade inflammation. The inner surface of the blood vessels is lined with endothelial cells; therefore, even low levels of circulating LPS can directly activate these cells and elicit specific cellular responses, such as an increase in the expression levels of cell adhesion molecules and proinflammatory mediators. In endothelial cells, LPS exposure results in an inflammatory response through activation of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases. Cynarin, a phytochemical found in artichokes, has several pharmacological properties against endothelial inflammation. In the present study, we discovered that cynarin suppressed the LPS-induced increase in the expression levels of vascular cell adhesion molecule-1 and proinflammatory mediators such as monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), and interleukin-1β in EA.hy926 cells. Further, cynarin inhibited the activation of p38 and NF-κB pathways by inducing the negative regulator mitogen-activated protein kinase phosphatase 3 (MKP-3) in LPS-stimulated EA.hy926 cells. In conclusion, cynarin alleviates inflammation by upregulating MKP-3, a negative regulator of p38 and NF-κB, and it may be a therapeutic option for treating endothelial inflammation-related diseases.
Keywords: Cynarin; MKP-3; endothelial inflammation; endotoxin.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- Bierhaus A, Chen J, Liliensiek B, Nawroth PP.. 2000. LPS and cytokine-activated endothelium. Semin Thromb Hemost. 26(5):571–588. - PubMed
-
- Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, Ngan HY.. 2008. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis. 29(9):1742–1750. - PubMed
-
- Chen X, Xiu M, Xing J, Yu S, Min D, Guo F.. 2017. Lanthanum chloride inhibits LPS mediated expressions of pro-inflammatory cytokines and adhesion molecules in HUVECs: Involvement of NF-κB-Jmjd3 signaling. Cell Physiol Biochem. 42(5):1713–1724. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous